Markers of Systemic Inflammatory Response Are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis

被引:0
|
作者
Gaitanidis, Apostolos [1 ]
Patel, Dhaval [1 ]
Nilubol, Naris [1 ]
Tirosh, Amit [1 ]
Sadowski, Samira [1 ]
Kebebew, Electron [1 ]
机构
[1] NCI, Endocrine Oncol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:S70 / S71
页数:2
相关论文
共 50 条
  • [31] Optimizing EUS Staging of Pancreatic Neuroendocrine Tumors (pNETs) Through FNA Confirmation of Nodal, Vascular, or Hepatic Metastasis and Determination of Adverse Prognostic Markers
    Gleeson, Ferga C.
    Levy, Michael J.
    Chari, Suresh T.
    Clain, Jonathan E.
    Clayton, Amy C.
    Henry, Michael
    Kendrick, Michael L.
    Pearson, Randall K.
    Petersen, Bret T.
    Rajan, Elizabeth
    Vege, Santhi Swaroop
    Takahashi, Naoki
    Thompson, Geoffrey B.
    Topazian, Mark D.
    Wang, Kenneth K.
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB237 - AB237
  • [32] SYSTEMIC INFLAMMATORY RESPONSE MARKERS IN PATIENTS WITH METASTATIC GERM CELL TUMORS UNDERGOING CHEMOTHERAPY MIGHT BE OF PROGNOSTIC VALUE
    Fankhauser, Christian
    Beyer, Joerg
    Sander, Sophia
    Poyet, Cedric
    Sulser, Tullio
    Hermanns, Thomas
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1053 - E1053
  • [33] Prognostic factors and survival in 144 patients with gastro-entero-pancreatic neuroendocrine tumors
    Panzuto, F
    Nasoni, S
    Cattaruzza, MS
    Milione, M
    Cassetta, S
    Tornatore, V
    Di Fonzo, M
    Capurso, G
    Corleto, VD
    Bordi, C
    Delle Fave, G
    GASTROENTEROLOGY, 2004, 126 (04) : A391 - A392
  • [34] Systemic Inflammatory Markers as a Prognostic Factor in Parotid Gland Tumors
    Tunc, Orhan
    Gonuldas, Burhanettin
    Kanlikama, Muzaffer
    CYPRUS JOURNAL OF MEDICAL SCIENCES, 2021, 6 (02): : 171 - 176
  • [35] Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors (PNETs): A Single-Center Case Control Study
    Onwere, Ike
    O'Dorisio, Thomas
    O'Dorisio, Sue M.
    DeYoung, Barry
    Yusuf, Menda
    PANCREAS, 2010, 39 (02) : 279 - 279
  • [36] Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs)
    Marinovic, Sonja
    Berkovic, Maja Cigrovski
    Zjacic-Rotkvic, Vanja
    Kapitanovic, Sanja
    CANCER GENETICS, 2022, 266 : 44 - 50
  • [37] Exploring phosphatase and tensin homolog (PTEN) loss as a potential predictive marker for response to everolimus in patients with pancreatic neuroendocrine tumors (PNETs)
    Khushman, Moh'd
    Slingerland, Joyce
    Fan, Yao-Shan
    Garcia-Buitrago, Monica
    Bustinza, Ernesto
    Restrepo, Maria
    Sussman, Daniel
    Rocha-Lima, Caio
    Hosein, Peter
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [38] RETRACTED: Pancreatic neuroendocrine tumors. Prognostic factors (Retracted Article)
    Cienfuegos, Javier A.
    Rotellar, Fernando
    Ruiz-Canela, Miguel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (10) : 738 - 738
  • [39] Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas
    Wang, De-shen
    Zhang, Dong-sheng
    Qiu, Miao-zhen
    Wang, Zhi-qiang
    Luo, Hui-yan
    Wang, Feng-hua
    Li, Yu-hong
    Xu, Rui-hua
    TUMOR BIOLOGY, 2011, 32 (04) : 697 - 705
  • [40] Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors
    Cetinkaya, Raziye Boyar
    Vatn, Morten
    Aabakken, Lars
    Bergestuen, Deidi S.
    Thiis-Evensen, Espen
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (06) : 734 - 741